1. Home
  2. CYTK vs LLYVA Comparison

CYTK vs LLYVA Comparison

Compare CYTK & LLYVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

N/A

Current Price

$72.72

Market Cap

10.7B

Sector

Health Care

ML Signal

N/A

Logo Liberty Media Corporation Series A Liberty Live

LLYVA

Liberty Media Corporation Series A Liberty Live

N/A

Current Price

$95.63

Market Cap

9.2B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
CYTK
LLYVA
Founded
1997
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
9.2B
IPO Year
2004
2025

Fundamental Metrics

Financial Performance
Metric
CYTK
LLYVA
Price
$72.72
$95.63
Analyst Decision
Strong Buy
Analyst Count
19
0
Target Price
$89.26
N/A
AVG Volume (30 Days)
1.8M
93.1K
Earning Date
05-05-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,368,000.00
$381,951,000.00
Revenue This Year
$7.37
N/A
Revenue Next Year
$310.19
$5.52
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.18
52 Week Low
$47.22
$74.38
52 Week High
$88.31
$106.06

Technical Indicators

Market Signals
Indicator
CYTK
LLYVA
Relative Strength Index (RSI) 42.80 43.69
Support Level $73.34 $93.31
Resistance Level $79.73 $99.16
Average True Range (ATR) 2.22 2.32
MACD -0.38 -0.61
Stochastic Oscillator 39.09 5.35

Price Performance

Historical Comparison
CYTK
LLYVA

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About LLYVA Liberty Media Corporation Series A Liberty Live

Liberty Live Holdings Inc consists of its ownership in Live Nation, its wholly owned subsidiary Quint and other minority investments. Quint is a provider of premium sports and entertainment experiences. Through exclusive rights agreements with sports leagues, event organizers, and governing bodies, Quint designs, develops, and sells official ticket-inclusive hospitality and single to multi-day experiential packages that may include on or off-site experiences, transportation, and hotel accommodations, with involvement of Quint personnel throughout the multi-day experiences. Live Nation is one of the live entertainment companies in the world, and the producer of live music concerts in the world, based on total fans that attend Live Nation events as compared to events of other promoters.

Share on Social Networks: